Abstract 1778: B7-H3-CAR T-cell therapy in immune-competent osteosarcoma models: Regnase-1 KO overcomes limited CAR T-cell expansion
Adeleye O. Adeshakin(St. Jude Children's Research Hospital), Stephen Gottschalk(St. Jude Children's Research Hospital), Christopher DeRenzo(St. Jude Children's Research Hospital), Phuong Nguyen(St. Jude Children's Research Hospital), Jessica Wagner(German Center for Neurodegenerative Diseases), Scott Perry, Jean‐Yves Métais(National Institutes of Health), Xiang Sun(St. Jude Children's Research Hospital), Giedre Krenciute(St. Jude Children's Research Hospital), Hongbo Chi(St. Jude Children's Research Hospital), Jason T. Yustein(Emory University), Peipei Zhou(St. Jude Children's Research Hospital), Hao Shi(St. Jude Children's Research Hospital), Trevor Cunningham(St. Jude Children's Research Hospital), Heather Sheppard(St. Jude Children's Research Hospital)
Cited by 3
Related Papers
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Regulation and function of mTOR signalling in T cell fate decisions
|Nature reviews. Immunology|2012|996